Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-09 Sale | 2024-05-10 4:04 pm | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 20,222 | $12.18 | $246,300 | 1,652,690 (Direct) | View |
| 2024-04-11 Sale | 2024-04-15 4:14 pm | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 13,558 | $12.19 | $165,214 | 1,672,912 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-23 Option Award | 2024-05-28 6:21 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 32,335 | $0 | 32,335 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-10 4:04 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 20,222 | $4.2 | 1,652,690 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-10 4:04 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 20,222 | $0 | 1,652,690 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 4:14 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 13,558 | $4.2 | 1,672,912 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 4:14 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 13,558 | $0 | 1,672,912 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 4:08 pm | N/A 2034-01-04 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 396,000 | $0 | 396,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-05 5:14 pm | N/A 2034-01-04 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 396,000 | $0 | 396,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:35 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 5:05 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 1,032,634 | $0 | 1,032,634 (Direct) | View |
| 2023-03-06 Disposition | 2023-03-08 5:05 pm | N/A 2032-02-16 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 672,634 | $0 | 1,032,634 (Direct) | View |
| 2022-10-25 Option Award | 2022-10-27 4:52 pm | N/A 2032-10-24 | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 205,000 | $0 | 205,000 (Direct) | View |
Ownership | 2022-09-14 6:10 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | Holles Natalie C. CEO | 0 | $0 | 1,686,470 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 6:11 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 28,700 | $0 | 28,700 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:33 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Holles Natalie C. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-25 Option Award | 2021-10-14 4:29 pm | N/A 2031-05-25 | Allakos Inc. | ALLK | Holles Natalie C. Director | 7,700 | $0 | 7,700 (Direct) | View |
Ownership | 2021-05-26 9:03 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 0 | $0 | 137,610 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:34 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Holles Natalie C. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 5:32 pm | N/A 2031-01-04 | Allakos Inc. | ALLK | Holles Natalie C. Director | 4,000 | $0 | 4,000 (Direct) | View |
Ownership | 2020-12-31 9:01 pm | N/A N/A | Allakos Inc. | ALLK | Holles Natalie C. Director | 0 | $0 | 14,000 (Indirect) | View |
| 2020-05-21 Option Award | 2020-05-26 8:52 pm | N/A 2030-05-20 | Rubius Therapeutics Inc. | RUBY | Holles Natalie C. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 320,348 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:29 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 104,439 | $60 | 0 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 97,609 | $59.37 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 5,715 | $9.4988 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 74,117 | $15.26 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 14,895 | $24.74 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 147,344 | $0 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 45,726 | $2.7649 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 6,891 | $27.39 | 399,787 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:15 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 505 | $59.21 | 54,704 (Direct) | View |